This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (64)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Economic Analysis of a Therapeutic Strategy

John M. Eisenberg, MD, MBA; Deborah S. Kitz, PhD

JAMA. 1986;255(12):1584-1588.

Abstract
Clinical, economic, and epidemiologic data were used to compare the costs of conventional inpatient care of osteomyelitis with the costs of early-discharge treatment using a once-daily parenteral antibiotic at home. Estimated expenses included inpatient medical care, outpatient visits, supplies, child care, home care, transportation, and lost productivity. Early-discharge treatment was associated with lower medical direct, nonmedical direct, and indirect expenses than conventional inpatient treatment. Estimated savings per patient ranged from $510 to $22,232 (demonstrating the wide differences in estimated savings when different sources of data on hospital costs are used). These savings are due to large decreases in inpatient costs, which are partially offset by increased outpatient costs. However, because outpatient costs are more often borne by patients than are inpatient costs, early-discharge treatment could be more expensive from the patient's perspective, despite its savings for the hospital and for society as a whole.

(JAMA 1986;255:1584-1588)

Author Affiliations
From the Section of General Medicine (Dr Eisenberg), the Center for Research in Day Surgery (Dr Kitz), and the Leonard Davis Institute of Health Economics (Drs Eisenberg and Kitz), University of Pennsylvania, Philadelphia.

Footnotes
Reprint requests to the Section of General Medicine, 3 Silverstein, Box 624, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (Dr Eisenberg).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service
Gilchrist et al.
J Antimicrob Chemother 2008;62:177-183.
ABSTRACT | FULL TEXT  

Evaluation of studies of health economics
Stone et al.
Evid. Based Nurs. 2002;5:100-104.
FULL TEXT  

Outpatient Parenteral Antimicrobial-Drug Therapy
Gilbert et al.
NEJM 1997;337:829-839.
FULL TEXT  

Cost-effectiveness of HA-1A Monoclonal Antibody for Gram-Negative Sepsis: Economic Assessment of a New Therapeutic Agent
Schulman et al.
JAMA 1991;266:3466-3471.
ABSTRACT  

Clinical Economics: A Guide to the Economic Analysis of Clinical Practices
Eisenberg
JAMA 1989;262:2879-2886.
ABSTRACT  

Home Intravenous Antibiotic Therapy Using a Programmable Infusion Pump
Williams et al.
Arch Intern Med 1989;149:1157-1160.
ABSTRACT  

The Medical Course of Cancer Patients With Fever and Neutropenia: Clinical Identification of a Low-Risk Subgroup at Presentation
Talcott et al.
Arch Intern Med 1988;148:2561-2568.
ABSTRACT  

Cost-effective Use of Antibiotics
Kunin
Arch Intern Med 1988;148:1709-1710.
ABSTRACT  

Cutting Into Cholesterol: Cost-effective AlternatiCost-effective Treating Hypercholesterolemia
Kinosian and Eisenberg
JAMA 1988;259:2249-2254.
ABSTRACT  

Outpatient Antibiotic Therapy for Osteomyelitis
Cohen and Weber
JAMA 1987;258:322-322.
ABSTRACT  

Savings From Outpatient Antibiotic Therapy for Osteomyelitis
Rehm and Weinstein
JAMA 1986;256:1002-1002.
ABSTRACT